TY - JOUR
T1 - Prostate Cancer With Peritoneal Carcinomatosis
T2 - A Robotic-assisted Radical Prostatectomy-based Case Series
AU - Goldenthal, Steven B.
AU - Reimers, Melissa A.
AU - Singhal, Udit
AU - Farha, Mark
AU - Mehra, Rohit
AU - Piert, Morand
AU - Tosoian, Jeffrey J.
AU - Modi, Parth K.
AU - Curci, Nicole
AU - Peabody, James
AU - Kleer, Eduardo
AU - Smith, David C.
AU - Morgan, Todd M.
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/9
Y1 - 2022/9
N2 - Objective: To aid in the diagnosis and treatment of patients with metastatic tumor seeding, an exceedingly rare phenomenon following minimally invasive urological surgery, additional case reports are needed. Materials and Methods: We report our experience with patients determined to have peritoneal carcinomatosis following robotic-assisted radical prostatectomy (RARP) and provide a descriptive summary of these unique cases. Results: Five cases of peritoneal carcinomatosis were identified, all of which occurred relatively late—between 8 and 13 years—following RARP. Four of the 5 cases had T3 disease at the time of prostatectomy. 68Ga-PSMA PET identified peritoneal carcinomatosis in 3 of 5 cases. Conclusion: Certain clinical factors, such as advanced pathologic stage at the time of prostatectomy, may predict risk for carcinomatosis following RARP. Additionally, next-generation imaging modalities, such as PSMA PET, may aid in identifying these metastases and are likely to identify increasing numbers of these patients as next-generation imaging becomes more widely available. Continued documentation and classification of this atypical presentation are needed to improve our understanding and management of this phenomenon.
AB - Objective: To aid in the diagnosis and treatment of patients with metastatic tumor seeding, an exceedingly rare phenomenon following minimally invasive urological surgery, additional case reports are needed. Materials and Methods: We report our experience with patients determined to have peritoneal carcinomatosis following robotic-assisted radical prostatectomy (RARP) and provide a descriptive summary of these unique cases. Results: Five cases of peritoneal carcinomatosis were identified, all of which occurred relatively late—between 8 and 13 years—following RARP. Four of the 5 cases had T3 disease at the time of prostatectomy. 68Ga-PSMA PET identified peritoneal carcinomatosis in 3 of 5 cases. Conclusion: Certain clinical factors, such as advanced pathologic stage at the time of prostatectomy, may predict risk for carcinomatosis following RARP. Additionally, next-generation imaging modalities, such as PSMA PET, may aid in identifying these metastases and are likely to identify increasing numbers of these patients as next-generation imaging becomes more widely available. Continued documentation and classification of this atypical presentation are needed to improve our understanding and management of this phenomenon.
UR - http://www.scopus.com/inward/record.url?scp=85131070441&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2022.04.002
DO - 10.1016/j.urology.2022.04.002
M3 - Article
C2 - 35472327
AN - SCOPUS:85131070441
SN - 0090-4295
VL - 167
SP - 171
EP - 178
JO - Urology
JF - Urology
ER -